Hereditary Motor and Sensory Neuropathy Type 1 (HMSN I)

Hereditary motor and sensory neuropathy type 1 (HMSN I) is a genetic disease that slowly damages the peripheral nerves. These nerves carry signals from the brain and spinal cord to the muscles (motor) and bring back feeling from the skin (sensory). In type 1, the main problem is in the myelin sheath, which is the “insulation” around the nerve. When this insulation is damaged or formed in an abnormal way, nerve signals become slow and weak. This causes weakness, wasting of muscles, and loss of feeling, mainly in the feet and hands. HMSN I is the same group of diseases that doctors also call Charcot-Marie-Tooth disease type 1 (CMT1). It usually runs in families in an autosomal dominant pattern, which means a child can be affected if one parent has the faulty gene.NCBI+2PM&R KnowledgeNow+2

Hereditary motor and sensory neuropathy type 1 (HMSN1) is a group of inherited nerve diseases in which the protective covering of the peripheral nerves (myelin) slowly becomes damaged. These nerves carry signals to the muscles (motor) and from the skin and joints (sensory). When the myelin is damaged, signals travel more slowly and more weakly, so muscles in the feet, legs, hands and arms become weak and thin, and feeling in these areas gradually decreases. Many doctors also call this condition Charcot-Marie-Tooth disease type 1 (CMT1). There is no cure yet, but many treatments can help with walking, balance, pain, and daily activities, and can protect the joints and feet from long-term damage. Wikipedia+2PM&R KnowledgeNow+2

HMSN1 usually starts in childhood or teenage years with frequent ankle sprains, “high-arched” feet, and difficulty running or climbing stairs. Over time, people may develop foot deformities such as pes cavus (very high arch), claw toes, and sometimes scoliosis (spine curvature). The main goals of care are not to “fix the genes” (because we cannot do that yet), but to keep the body as strong, flexible and safe as possible, reduce pain, and support emotional health and independence. PM&R KnowledgeNow+2Orthobullets+2

---

Other names

Doctors and books use several other names for hereditary motor and sensory neuropathy type 1. All these names point to the same general group of diseases:

• Charcot-Marie-Tooth disease type 1 (CMT1) – the most common name in modern neurology.NCBI+1

• Hereditary motor and sensory neuropathy type I (HMSN I) – an older but still used name, especially in older textbooks and research papers.PM&R KnowledgeNow+1

• Peroneal muscular atrophy (demyelinating form) – used because leg muscles around the peroneal nerve (outside of the lower leg) become weak and wasted.Wikipedia

• CMT1A, CMT1B, CMT1C, CMT1D, CMT1E – these are genetic subtypes inside type 1, based on which gene is changed.Muscular Dystrophy Association+1

All of these names describe a chronic, slowly worsening neuropathy that affects both movement and feeling, mainly in the feet, legs, hands, and arms.NCBI+1

---

Types

The “types” here usually mean the genetic subtypes of CMT1 / HMSN I. The main types are:

1. CMT1A – This is the most common subtype. It is usually caused by a duplication (extra copy) of the PMP22 gene on chromosome 17. This extra copy makes too much PMP22 protein, which harms the myelin, leading to slow nerve signals. Patients often have childhood-onset weakness, high arches, and foot drop.Muscular Dystrophy Association+1

2. CMT1B – This type is usually due to a change (mutation) in the MPZ gene, which makes myelin protein zero, a key myelin component. The faulty protein causes unstable myelin and demyelination. Symptoms can start in childhood or later and may be more or less severe depending on the exact mutation.Wiley Online Library+1

3. CMT1C – Often linked to mutations in the LITAF gene. LITAF helps control the handling and breakdown of proteins inside cells. When it is abnormal, myelin-forming Schwann cells do not process proteins correctly, and the myelin sheath becomes damaged, causing neuropathy.SciELO Costa Rica+1

4. CMT1D – Usually associated with mutations in the EGR2 gene, which is a transcription factor that controls many genes important for myelin. When EGR2 is altered, several myelin genes are mis-regulated, leading to more widespread and sometimes more severe demyelination.SciELO Costa Rica+1

5. CMT1E – Often caused by point mutations (single-letter changes) in PMP22 instead of a duplication. These missense or nonsense changes produce abnormal PMP22 protein that disturbs myelin structure, sometimes causing a more severe or earlier-onset disease.SciELO Costa Rica+1

Although other rare gene changes can give CMT1-like pictures, these main subtypes explain most cases of HMSN I in many populations studied around the world.Wiley Online Library+1

---

Causes

Here “causes” mainly mean genetic reasons and related risk factors that lead to HMSN I.

1. PMP22 gene duplication – The most frequent cause of CMT1A is an extra copy of the PMP22 gene. This extra gene leads to excess PMP22 protein in myelin and makes the myelin unstable. This is the single most common cause of hereditary motor and sensory neuropathy type 1 worldwide.Wiley Online Library+1

2. PMP22 point mutations – Some patients do not have an extra copy but instead have small changes inside PMP22. These mutations can change the shape of the protein, harm myelin, and produce a CMT1E-type picture.SciELO Costa Rica+1

3. MPZ (myelin protein zero) mutations – MPZ is a key structural protein in myelin. Mutations in MPZ disturb how myelin layers stick together, causing demyelinating neuropathy labeled CMT1B.Wiley Online Library+1

4. LITAF gene mutations – LITAF controls how cells break down certain proteins. Faults in this gene (CMT1C) cause abnormal protein handling in Schwann cells and lead to thin or unstable myelin.SciELO Costa Rica+1

5. EGR2 gene mutations – EGR2 is a transcription factor. It turns many myelin genes on and off. Mutations in EGR2 change this control and can cause severe demyelinating neuropathy labeled CMT1D.SciELO Costa Rica+1

6. PRX (periaxin) mutations – Periaxin helps anchor myelin to the underlying axon. Changes in the PRX gene can cause a demyelinating neuropathy that is often early in onset and may be severe, overlapping with CMT1 or related disorders.SciELO Costa Rica+1

7. PMP2 mutations – PMP2 encodes another myelin protein. Rare mutations in PMP2 can give a CMT1-like disease, showing that even small myelin proteins are important for nerve insulation.Taylor & Francis Online+1

8. GJB1 (connexin 32) mutations with demyelinating pattern – GJB1 changes usually cause X-linked CMT (CMTX), but in some families the electrodiagnostic pattern looks demyelinating, very similar to CMT1, so clinically they may be grouped with hereditary motor and sensory neuropathies.Wikipedia+1

9. NEFL gene mutations – NEFL codes for neurofilament light chain, important for axon shape and function. Some NEFL mutations cause a demyelinating or intermediate neuropathy that can clinically mimic HMSN I.Taylor & Francis Online+1

10. Other rare myelin gene mutations – Genes like SH3TC2, FGD4, and others can produce demyelinating hereditary neuropathies. In some settings they may be classified with CMT1 or HMSN I because of the similar nerve conduction pattern and pathology.Taylor & Francis Online+1

11. Autosomal dominant inheritance – Many CMT1 genes follow autosomal dominant inheritance. Having one copy of the altered gene from one affected parent is enough to cause HMSN I. Family history is therefore a strong “cause” and risk factor.NCBI+1

12. De novo (new) mutations – Sometimes a child develops HMSN I with no previous family history. In these cases, the mutation arises for the first time in the egg, sperm, or early embryo. The new mutation then behaves in an autosomal dominant fashion in later generations.Taylor & Francis Online+1

13. Parental germline mosaicism – Rarely, a parent may carry the mutation in only a portion of reproductive cells, with no symptoms. This “hidden” mosaicism can cause a child to have HMSN I, appearing as if there is no family history, even though the gene change came from the parent.Taylor & Francis Online+1

14. Copy-number variation around chromosome 17p11.2 – The region around PMP22 is prone to deletions and duplications. Structural changes in this region can disrupt PMP22 dosage and cause HMSN I.Wiley Online Library+1

15. Consanguinity (parents related by blood) – In some populations, marriages between close relatives increase the chance that both parents carry rare neuropathy gene changes. Although CMT1 is often dominant, mixed or complex patterns can appear more frequently in consanguineous families.ScienceDirect+1

16. Unidentified gene mutations – Even with large gene panels and sequencing, some people with clear HMSN I still have no gene found. This suggests there are additional, still unknown, genetic causes.Mayo Clinic Laboratories+1

17. Modifier genes – Some people with the same main mutation have milder or more severe disease. Research suggests that other genes can modify the effect of the main CMT1 gene and influence how badly the nerves are damaged.ScienceDirect+1

18. Mitochondrial and cellular stress pathways – Although CMT1 is mainly a myelin disease, studies show that mitochondrial function, protein folding, and cellular stress pathways are disturbed. These secondary changes can worsen nerve damage and act as additional biological “causes” of disease progression.ScienceDirect+1

19. Age-related myelin vulnerability – As people age, myelin repair becomes less efficient. In someone who already has a CMT1 gene mutation, natural aging of nerves may speed up symptom progression.NCBI+1

20. Environmental and lifestyle modifiers – While they do not cause HMSN I by themselves, factors such as repetitive ankle injuries, poor footwear, or other illnesses that stress peripheral nerves may unmask or worsen symptoms in a person who already carries a CMT1 gene mutation.NCBI+1

---

Symptoms

1. Slowly progressive weakness in feet and ankles – One of the earliest signs is weakness in the muscles that lift the front of the foot. Children may run more slowly than friends, trip often, or have trouble standing on their heels. This weakness slowly worsens over many years.Mayo Clinic+1

2. Foot drop and high-stepping gait – Because the ankle cannot lift properly, the toes drag on the ground. To avoid this, people lift the knees higher when walking, which is called a high-stepping or “steppage” gait.Mayo Clinic+1

3. High arches (pes cavus) – The muscles that pull the foot up and down become imbalanced. This makes the middle of the foot very high, with more pressure on the ball and heel. Over time, this fixed high arch is common in HMSN I.Mayo Clinic+1

4. Curled toes (hammertoes) – Small muscles inside the foot become weak, while stronger tendons pull the toes downward. The toes become claw-like or curled, which can cause pain, calluses, and trouble finding comfortable shoes.Mayo Clinic+1

5. Frequent ankle sprains – Weak ankle muscles and unstable joints make rolling the ankle easy, especially on uneven ground. Many patients report repeated sprains or minor injuries in adolescence and early adulthood.Muscular Dystrophy Association+1

6. Muscle wasting in the lower legs – Over time, the muscles in the calves shrink because the nerves are not working well. This gives the lower legs a thin, “inverted champagne bottle” look, with narrow calves and relatively larger thighs.Mayo Clinic+1

7. Numbness in feet and toes – Damage to sensory fibers reduces feeling. People may notice they cannot feel light touch, temperature, or pain as well in their feet. They might not notice small injuries, cuts, or blisters.NCBI+1

8. Tingling or “pins and needles” – Many patients describe tingling, buzzing, or burning sensations in the feet and later in the hands. These unpleasant feelings come from irritated or misfiring sensory fibers.Mayo Clinic+1

9. Loss of vibration and position sense – People may have trouble feeling vibration from a tuning fork or knowing where their toes are without looking. This loss of deep sensation makes balance worse, especially in the dark.PFM Journal+1

10. Weakness in hands and fingers – As the disease progresses upward, hand muscles become weak. Tasks such as buttoning clothes, opening jars, writing, or using tools become harder.NCBI+1

11. Reduced tendon reflexes – Doctors often find that ankle reflexes and sometimes knee or upper limb reflexes are weak or absent. This is because the reflex loop needs healthy sensory and motor fibers, which are damaged in HMSN I.NCBI+1

12. Foot and leg cramps – Overworked or mis-controlled muscles can cramp, especially at night or after long walking. These cramps may be painful but do not usually mean rapid worsening of the disease.Mayo Clinic+1

13. Balance problems and falls – With weak muscles and poor sensation, standing and walking on uneven or dark surfaces are difficult. People may sway, stumble, or fall more often, and they may avoid activities like running or climbing stairs quickly.NCBI+1

14. Spinal or skeletal deformities – Some patients develop scoliosis (curving of the spine) or other posture problems because muscle weakness is uneven. These changes may be mild or require bracing or surgery in more serious cases.Wikipedia+1

15. Fatigue and reduced endurance – Moving with weak muscles and unstable joints uses more energy. People with HMSN I often feel tired more easily and may need to rest more during the day, even if their heart and lungs are normal.NCBI+1

---

Diagnostic tests

Physical examination tests

1. Complete neurologic examination – The doctor checks muscle strength, tone, reflexes, and sensation in the arms and legs. In HMSN I, they look for distal weakness, muscle wasting, high arches, hammertoes, and reduced tendon reflexes. The overall pattern (weak feet and hands, preserved upper arms and thighs) gives an important first clue.NCBI+1

2. Gait (walking) assessment – The doctor watches how the person walks, runs, and turns. A high-stepping gait, frequent tripping, or difficulty walking on heels suggest foot drop from peripheral neuropathy. This simple bedside observation helps decide if more tests are needed.Mayo Clinic+1

3. Foot and skeletal inspection – The feet, ankles, and spine are checked for high arches, hammertoes, calluses, and scoliosis. These structural changes build slowly over years in CMT1 and support the diagnosis when combined with family history.Wikipedia+1

4. Reflex testing – Using a reflex hammer, the doctor tests ankle, knee, and upper limb reflexes. In HMSN I, ankle reflexes are often absent early, and knee reflexes may become weak later. Reduced reflexes in the presence of weakness and sensory loss strongly suggest a neuropathy.NCBI+1

5. Sensory bedside testing – Light touch, pin-prick, vibration (with a tuning fork), and joint position sense are checked. Typical findings are reduced vibration and position sense in the toes and feet, with milder loss to pain or temperature. This bedside test helps map how far the neuropathy has spread.NCBI+1

Manual or functional tests

6. Manual muscle testing (MMT) – The examiner pushes against the patient’s limbs in different directions and grades strength on a simple scale. In HMSN I, weakness is usually worse in ankle dorsiflexion (lifting the foot) and toe extension early on, then later in hand muscles. MMT gives a simple, repeatable way to track change over time.PM&R KnowledgeNow+1

7. Heel-toe walking test – The patient is asked to walk on heels and then on toes. Difficulty walking on heels suggests weakness of the muscles that lift the foot. Difficulty walking on toes suggests weakness in the calf muscles. This test is quick and sensitive for early distal weakness.NCBI+1

8. Romberg balance test – The patient stands with feet together, first with eyes open, then closed. In neuropathy, especially with reduced joint position sense, closing the eyes often makes balance much worse, and the person may sway or fall. This test shows the importance of sensory input for balance.NCBI+1

9. Timed walking or functional scales – Simple timed tests, such as how long it takes to walk 10 meters or climb a short stair, help measure disability. In CMT, there are specific scales (for example, CMT Neuropathy Score) that combine strength, sensation, and function into a numeric score used in clinics and research.NCBI+1

10. Tuning fork vibration test as a focused manual test – A vibrating tuning fork is placed on the big toe and ankles. The patient says when the vibration stops. In HMSN I, vibration sense often fades early, even before obvious numbness is noticed. This simple test helps detect early sensory involvement.PFM Journal+1

Laboratory and pathological tests

11. Routine blood tests to exclude other causes – Tests such as blood sugar, vitamin B12, thyroid function, kidney and liver function are done to rule out common acquired neuropathy causes. In pure HMSN I, these results are usually normal, which supports a hereditary rather than acquired neuropathy.NCBI+1

12. Genetic testing for CMT1 genes – A blood sample is sent to a specialized laboratory. First-line tests look for PMP22 duplication and common CMT1 mutations. Larger gene panels can check many neuropathy genes at once. A positive result confirms the genetic subtype, such as CMT1A or CMT1B.Mayo Clinic+2Mayo Clinic Laboratories+2

13. Targeted family testing – Once a disease-causing mutation is found in one family member, other relatives can be tested for the same change. This helps with family planning, early diagnosis, and genetic counseling in families with HMSN I.NCBI+1

14. Nerve biopsy (usually sural nerve) – In the past, a small piece of nerve from the leg was sometimes taken and examined under the microscope. In HMSN I, this can show segmental demyelination and “onion bulb” formations from repeated myelin loss and repair. Today, biopsy is rarely needed because genetic and electrodiagnostic tests give enough information.Wiley Online Library+1

15. Cerebrospinal fluid (CSF) analysis (selective) – In unclear cases, doctors may take a small sample of the fluid around the brain and spinal cord to exclude inflammatory neuropathies like CIDP. In pure HMSN I, CSF protein is usually normal or only slightly raised, helping to distinguish it from acquired demyelinating diseases.NCBI+1

Electrodiagnostic tests

16. Nerve conduction studies (NCS) – Small electrical pulses are given to nerves, and responses are recorded along their path. In HMSN I, conduction velocities are uniformly slow, and response sizes may be reduced. This pattern of diffuse demyelination is a key sign that supports CMT1 rather than an axonal neuropathy.NCBI+2Taylor & Francis Online+2

17. Electromyography (EMG) – A fine needle electrode is placed into muscles to record electrical activity. In HMSN I, EMG may show chronic denervation and re-innervation patterns, meaning that some nerve branches have died and others have grown to take over. EMG helps confirm that weakness is due to neuropathy rather than muscle disease.NCBI+1

Imaging tests

18. Ultrasound of peripheral nerves – High-resolution ultrasound can show thickened or enlarged peripheral nerves in inherited demyelinating neuropathies. In some patients with CMT1, nerves look enlarged along their length, which supports a hereditary cause. Ultrasound is painless and can be used alongside NCS.NCBI+1

19. Magnetic resonance imaging (MRI) of nerves or spine – MRI can show nerve root or plexus enlargement and can help rule out other structural problems. In HMSN I, MRI sometimes shows enlarged nerve roots or diffuse signal changes, but it is mainly used to exclude other diseases, not to diagnose CMT1 alone.NCBI+1

20. X-rays of feet and spine – Simple X-rays show bone and joint changes from long-standing muscle imbalance, such as high arches, hammertoes, and scoliosis. They help surgeons and orthopedists plan braces or corrective surgery if needed, and they document the structural impact of HMSN I over time.Wikipedia+1

Non-pharmacological treatments (therapies and others)

Below are 20 non-drug treatments commonly used to manage hereditary motor and sensory neuropathy type 1. Together they form the backbone of care.

1. Physical therapy and strengthening exercises
Regular physical therapy is one of the most important treatments for HMSN1. A physiotherapist teaches gentle strengthening exercises for the lower legs, feet, hands and core muscles to slow muscle wasting and help maintain walking ability. The purpose is to keep muscles as strong and flexible as possible without over-fatiguing them. The mechanism is simple: repeated, carefully controlled movement helps muscles keep their size and power and supports the joints, which reduces the risk of falls and deformities. PM&R KnowledgeNow+2ScienceDirect+2

2. Stretching and range-of-motion programs
Daily stretching of ankles, knees, hips, fingers and wrists helps prevent contractures (permanent stiffening of joints). A therapist teaches slow, comfortable stretches that are held for several seconds and repeated. The purpose is to keep joints moving through their full range so that walking and using the hands stays easier for a longer time. Mechanistically, stretching lengthens the soft tissues around joints, such as muscles and tendons, and reduces stiffness caused by weak muscles that tend to shorten when they are not used fully. PM&R KnowledgeNow+1

3. Occupational therapy and adaptive techniques
Occupational therapists focus on everyday activities like dressing, writing, cooking, and using a computer. They suggest new ways to do tasks, teach joint-protection techniques, and recommend aids such as built-up pens or easy-grip tools. The purpose is to keep people independent at school, work and home. The mechanism is environmental adaptation: by changing tools and methods, the person uses less effort and places less strain on weak muscles and numb hands and feet. PM&R KnowledgeNow+2Dr.Oracle+2

4. Gait training and walking pattern correction
Gait training means practicing safe walking patterns, sometimes with a treadmill, balance bars, or video feedback. The purpose is to reduce tripping, improve foot placement and make walking more energy-efficient. The mechanism is motor learning: by repeating better movements, the brain and remaining healthy nerves “learn” safer patterns that partly compensate for weak ankle muscles and poor sensation. Medical Journals Sweden+1

5. Balance and coordination exercises
Balance training may include standing on different surfaces, using balance boards, or practicing single-leg stance with support. The purpose is to reduce falls and build confidence in walking on uneven ground. Mechanistically, these exercises train the brain to rely more on vision and inner-ear signals when sensation from the feet is reduced, and they strengthen postural muscles that help keep the body upright. Medical Journals Sweden+1

6. Ankle-foot orthoses (AFOs)
AFOs are light braces worn inside or around the shoe to hold the ankle in a more stable position and prevent “foot drop” and tripping. The purpose is to improve safety, walking speed and endurance. The mechanism is mechanical support: the brace keeps the ankle at a safe angle so the toes clear the ground, and it shares some of the work of weak muscles, which also reduces fatigue. PM&R KnowledgeNow+2SAGE Journals+2

7. Custom footwear and insoles
People with HMSN1 often need shoes with good ankle support, wide toe boxes, and custom insoles to accommodate high arches or claw toes. The purpose is to improve comfort, protect fragile skin, and reduce calluses and ulcers. The mechanism is pressure redistribution: well-designed shoes spread body weight more evenly across the foot and help keep the foot in a more neutral position. PMC+2nhs.uk+2

8. Hand splints and functional braces
For hand weakness, splints or wrist-hand orthoses can support the wrist in a neutral position and allow fingers to move more effectively. The purpose is to improve grip for writing, typing and self-care tasks. Mechanistically, the splint stabilizes joints and lets the remaining finger flexor muscles work in a more efficient position, which can compensate partly for intrinsic hand muscle weakness. PM&R KnowledgeNow+1

9. Aquatic (water) therapy
Exercising in warm water takes weight off the joints and makes movement easier and less painful. The purpose is to strengthen muscles and improve cardiovascular fitness while reducing stress on weak ankles and knees. The mechanism is buoyancy: water supports the body while providing gentle resistance, so muscles work without the full load of gravity. ScienceDirect+1

10. Respiratory therapy when needed
Most people with HMSN1 do not have severe breathing problems, but some subtypes can weaken respiratory muscles. A respiratory therapist may teach breathing exercises or recommend devices such as cough-assist machines. The purpose is to maintain lung function and reduce the risk of chest infections. Mechanistically, training the respiratory muscles and mechanically assisting cough helps move air and mucus more effectively despite weak muscles. PMC+1

11. Pain psychology and cognitive-behavioral therapy (CBT)
Chronic neuropathic pain can be emotionally exhausting. Psychological therapies such as CBT teach skills for coping with pain, stress and sleep problems. The purpose is not to say “the pain is in your head” but to give tools to reduce suffering and improve mood and function. Mechanistically, CBT helps reframe thoughts about pain, lowers anxiety, and changes behavior patterns that can make pain worse, such as inactivity or fear of movement. ScienceDirect+1

12. Fatigue management and energy-conservation training
Fatigue is common in HMSN1. Therapists teach pacing, planning rest breaks, and using tools (like rollators or sit-stools) to save energy for the most important tasks. The purpose is to reduce exhaustion and keep activity levels more steady across the day. The mechanism is behavioral: by balancing activity and rest and using assistive devices, the body avoids repeated cycles of overexertion and crash. ScienceDirect+1

13. Fall-prevention and home safety modifications
Simple home changes such as removing loose rugs, adding grab bars, using night lights, and improving bathroom safety can dramatically lower fall risk. The purpose is to prevent fractures and head injuries in people with weak ankles and sensory loss. Mechanistically, fewer obstacles and more stable surfaces reduce the demands on a compromised balance system. Medical Journals Sweden+1

14. Foot care and podiatry
Because sensation is reduced, small injuries to the feet can go unnoticed and turn into ulcers or infections. Regular podiatry care, nail trimming, and daily self-inspection are vital. The purpose is early detection and treatment of skin problems. Mechanistically, close monitoring finds problems at a stage where simple measures—like off-loading pressure or treating calluses—can prevent serious complications. nhs.uk+1

15. Genetic counseling
HMSN1 is inherited, often in an autosomal dominant pattern. Genetic counseling helps families understand how the condition is passed on, what testing is available, and what reproductive options exist. The purpose is informed decision-making and emotional support. The mechanism is education plus risk calculation based on family history and genetic test results, which helps families plan pregnancies and screening. PM&R KnowledgeNow+1

16. Vocational rehabilitation and school accommodations
Specialists can advise on workplace or school adjustments such as ergonomic desks, extra time for walking between classes, or flexible schedules. The purpose is to keep people employed or in education as long and as comfortably as possible. Mechanistically, adapting the environment reduces physical strain and allows the person’s skills to shine despite physical limits. PM&R KnowledgeNow+1

17. Psychological counseling and peer support
Living with a lifelong condition can cause sadness, anxiety or frustration. Counseling and CMT support groups give a safe place to share experiences and learn coping strategies. The purpose is to protect mental health and reduce isolation. Mechanistically, social support and therapy strengthen emotional resilience and can lower perceived pain and fatigue. ScienceDirect+1

18. Weight management and general fitness programs
Extra body weight puts more strain on weak ankles and knees and may worsen pain and fatigue. Dietitians and trainers can design safe nutrition and exercise plans. The purpose is to keep a healthy weight and cardiovascular fitness. Mechanistically, less weight reduces mechanical stress on joints, while better fitness improves endurance and mood. ScienceDirect+1

19. Yoga, Tai Chi and mindful movement
Gentle movement practices such as yoga and Tai Chi can improve flexibility, balance and body awareness. The purpose is to complement physical therapy with low-impact, relaxing exercises. Mechanistically, these activities train postural control and breathing, and may reduce stress hormones, which in turn can lessen muscle tension and pain perception. Medical Journals Sweden+1

20. Participation in clinical trials
For some people, joining a clinical trial is an option. Trials may test new drugs, gene therapies, devices or rehab programs. The purpose is to gain access to potential new treatments and help advance science. Mechanistically, candidates are carefully monitored and receive standardized interventions according to strict research protocols designed to test safety and effectiveness. AFM Téléthon+2Frontiers+2

---

Drug treatments

There is no FDA-approved drug that can cure or slow hereditary motor and sensory neuropathy type 1 directly. Medicines are used to treat symptoms such as joint pain, neuropathic pain, muscle cramps, sleep problems and mood disorders. Most of the drugs below are FDA-approved for conditions like neuropathic pain, depression, seizures or insomnia and are used off-label in HMSN1 under specialist guidance. ScienceDirect+2nhs.uk+2

Because of space limits, doses are given only as general adult starting ranges from FDA labels; exact dosing must always be individualized by a doctor.

1. Ibuprofen (NSAID pain reliever)
Ibuprofen is a non-steroidal anti-inflammatory drug used for joint and muscle pain. A typical adult dose is 200–400 mg every 6–8 hours with food, up to a daily maximum defined by the label and doctor. The purpose in HMSN1 is to ease musculoskeletal pain from abnormal foot mechanics and joint strain. It works by blocking COX enzymes and reducing prostaglandins, which lowers pain and inflammation. Common side effects include stomach upset, heartburn, and, with long use, risk of ulcers or kidney problems. nhs.uk+1

2. Naproxen (NSAID pain reliever)
Naproxen is another NSAID often used for longer-lasting joint pain. Adults may start around 250–500 mg twice daily with food, but the exact schedule depends on the product. The purpose is similar to ibuprofen: to reduce joint and muscle pain that interferes with walking and sleep. It works by inhibiting prostaglandin production. Side effects include stomach irritation, increased bleeding risk, and, in some cases, fluid retention or blood pressure changes. Medscape+1

3. Acetaminophen (paracetamol)
Acetaminophen is a simple pain reliever and fever reducer that does not strongly reduce inflammation but is often easier on the stomach than NSAIDs. Typical adult doses are 500–1,000 mg every 4–6 hours, within the daily maximum to avoid liver damage. The purpose is to manage mild to moderate musculoskeletal pain, especially in people who cannot tolerate NSAIDs. It blocks pain signaling in the central nervous system. Main risk is liver toxicity with high doses or when combined with alcohol. nhs.uk+1

4. Gabapentin (antiepileptic for neuropathic pain)
Gabapentin is approved for nerve pain in conditions like postherpetic neuralgia and is widely used off-label for peripheral neuropathic pain. Doses are usually started low (for example 100–300 mg at night) and slowly increased several times a day as tolerated. The purpose in HMSN1 is to reduce burning, tingling or shooting neuropathic pain. It binds to calcium channels in nerve cells and decreases the release of excitatory neurotransmitters. Side effects include dizziness, sleepiness and weight gain. nhs.uk+2PMC+2

5. Pregabalin (neuropathic pain and anxiety drug)
Pregabalin is similar to gabapentin and is FDA-approved for several neuropathic pain conditions. It is often given twice daily starting at low doses and increased as needed. The purpose is to calm nerve over-activity causing burning and stabbing pain sensations. It acts on voltage-gated calcium channels to reduce neurotransmitter release. Side effects include dizziness, drowsiness, swelling of legs and weight gain. PMC+1

6. Duloxetine (SNRI antidepressant with pain effect)
Duloxetine is an SNRI antidepressant approved for diabetic neuropathic pain, depression and anxiety. Typical adult dosing starts at 30 mg daily and may increase. The purpose in HMSN1 is dual: treat neuropathic pain and help with low mood or anxiety. It blocks reuptake of serotonin and norepinephrine in the brain and spinal cord, which can dampen pain pathways. Side effects may include nausea, dry mouth, increased sweating and sleep changes. nhs.uk+1

7. Amitriptyline (tricyclic antidepressant for pain)
Amitriptyline is an older antidepressant often used in very low doses at night (for example 10–25 mg) to treat neuropathic pain and help sleep. The purpose in HMSN1 is to reduce burning pain and improve sleep continuity. It blocks reuptake of serotonin and norepinephrine and has additional effects on other receptors that change pain perception. Side effects include dry mouth, constipation, drowsiness and, rarely, heart rhythm changes, so careful monitoring is needed. nhs.uk+1

8. Nortriptyline (tricyclic with slightly fewer side effects)
Nortriptyline is related to amitriptyline but is sometimes better tolerated. It is also used off-label for neuropathic pain, starting with small night-time doses. The purpose and mechanism are similar: it enhances pain-modulating neurotransmitters. Common side effects are dry mouth, constipation, dizziness and sleep changes; it may be safer for some people with cardiovascular risks but still needs monitoring. ScienceDirect+1

9. Carbamazepine (antiepileptic for sharp shooting pain)
Carbamazepine is a seizure medicine also used for trigeminal neuralgia, a severe facial nerve pain, and may be tried for certain sharp neuropathic pains. Doses start low and are titrated up while checking blood tests for safety. The purpose is to reduce sudden electric-shock-like pains. It stabilizes over-active sodium channels in nerve cells. Side effects include dizziness, nausea, low blood counts and rare serious skin reactions, so it must be used with strict medical supervision. ScienceDirect+1

10. Tramadol (weak opioid and SNRI-like pain reliever)
Tramadol is used for moderate pain when simpler drugs are not enough. It is usually prescribed in low doses, sometimes only on the worst-pain days. The purpose is to improve function by reducing combined musculoskeletal and neuropathic pain. It weakly stimulates opioid receptors and also inhibits serotonin and norepinephrine reuptake. Side effects include nausea, dizziness, constipation, and risk of dependence or serotonin syndrome when combined with other serotonergic drugs, so doctors use it cautiously. PMC+1

11. Baclofen (muscle relaxant for cramps and spasticity)
Baclofen is a muscle relaxant mainly used for spasticity but sometimes tried for painful muscle cramps. Low oral doses are started and slowly increased. The purpose is to reduce painful cramps and stiffness in legs or back. It activates GABA-B receptors in the spinal cord, which lowers the activity of motor neurons. Side effects include sleepiness, weakness and dizziness; doses must not be stopped suddenly because of withdrawal risk. PMC+1

12. Tizanidine (muscle relaxant)
Tizanidine is another muscle relaxant sometimes used for muscle tone problems. It is taken several times a day at low doses. The purpose is similar to baclofen: ease stiffness and cramps that worsen pain and limit movement. It works as an alpha-2 adrenergic agonist, reducing nerve impulses that cause muscle contraction. Side effects include drowsiness, dry mouth and low blood pressure. ScienceDirect+1

13. Topical lidocaine patches or gels
Lidocaine patches or gels can be placed on painful skin areas, such as the tops of the feet. The purpose is to give local pain relief without affecting the whole body. Lidocaine blocks sodium channels in peripheral nerves, temporarily stopping pain signals in that area. Side effects are usually mild, such as skin irritation, but large areas should not be covered for too long to avoid systemic absorption. nhs.uk+1

14. Capsaicin cream or high-dose patches
Capsaicin is derived from chili peppers and is used in creams or special patches for nerve pain. It first causes a burning feeling, then reduces pain over time. The purpose in HMSN1 is to lessen localized burning pain in the feet or legs. It works by over-activating TRPV1 receptors on pain fibers, leading to temporary depletion of substance P and other pain transmitters. Side effects are mainly local burning or redness. ScienceDirect+1

15. Sertraline or other SSRIs (for mood and adjustment)
Sertraline is an SSRI antidepressant used for depression and anxiety. In HMSN1 it does not treat nerve damage directly but helps people cope with chronic illness. Typical adult doses start low and are gradually increased. The mechanism is increased serotonin levels in the brain, which can improve mood and anxiety. Side effects include nausea, insomnia or sleepiness, sexual side effects, and, rarely, changes in bleeding or mood. ScienceDirect+1

16. Melatonin (sleep regulation)
Melatonin is a hormone supplement used for insomnia or disturbed sleep and is widely available and FDA-regulated as a dietary supplement. In HMSN1, better sleep can lower daytime fatigue and pain perception. Low doses are usually taken 30–60 minutes before bedtime. Melatonin acts on sleep-related receptors in the brain to adjust the sleep-wake cycle. Side effects are usually mild, such as morning grogginess or vivid dreams. MDPI+1

17. Proton pump inhibitors (for stomach protection with NSAIDs)
Drugs like omeprazole may be prescribed when long-term NSAIDs are needed to protect the stomach lining. The purpose is to lower the risk of ulcers and bleeding. They work by blocking the proton pump in stomach cells, which reduces acid production. Side effects can include headache, diarrhea or, with very long use, changes in mineral absorption; they are used only when clearly needed. nhs.uk+1

18. Vitamin B12 injections (for confirmed deficiency)
Some people with neuropathy also have low vitamin B12, which can worsen nerve problems. In this case, B12 injections (for example, cyanocobalamin) are given regularly. The purpose is to correct deficiency and support nerve health. B12 is needed for myelin formation and DNA synthesis. Side effects are usually mild; the key is not to give injections “just in case” but when deficiency is proven by blood tests. PMC+2Preprints+2

19. Vitamin D supplements (for bone and muscle support)
Low vitamin D is common and can weaken bones and muscles. In HMSN1, vitamin D supplementation after blood testing helps reduce fracture risk. Doses are based on the level and guideline recommendations. Vitamin D improves calcium absorption in the gut and supports bone mineralization and muscle function. Side effects are rare at prescribed doses but very high doses can cause high calcium levels. ScienceDirect+1

20. Vaccines (e.g., influenza, pneumonia, COVID-19)
Although not “drugs for HMSN1”, vaccines protect against infections that can seriously weaken already fragile muscles and nerves. The purpose is prevention of complications such as pneumonia or severe viral illness. They work by training the immune system to recognize specific germs without causing the full disease. Side effects are usually mild (sore arm, brief fever), and schedules follow public health guidelines. Mayo Clinic+1

---

Dietary molecular supplements

Evidence for supplements specifically in HMSN1 is still limited, but several nutrients are being studied as adjuncts to standard care. They should never replace medical treatment.

1. Coenzyme Q10 (CoQ10)
CoQ10 is a vitamin-like substance involved in mitochondrial energy production. A small clinical trial in CMT tested whether CoQ10 could improve weakness, fatigue and pain. Typical supplement doses in studies range from 100–300 mg per day, but exact dosing for HMSN1 is not established. The purpose is to support energy metabolism in muscle and nerve cells. Mechanistically, CoQ10 shuttles electrons in the mitochondrial respiratory chain and also acts as an antioxidant. Evidence is still preliminary. ClinicalTrials.gov+1

2. Omega-3 fatty acids (EPA/DHA)
Omega-3s from fish oil or algae are anti-inflammatory fats that may support nerve cell membranes. Usual doses in supplements range from 500–2,000 mg combined EPA/DHA daily, as advised by a clinician. The purpose is to reduce low-grade inflammation and support cardiovascular health and possibly nerve function. Mechanistically, omega-3s are incorporated into cell membranes and can change inflammatory signaling molecules. Evidence in HMSN1 is indirect but promising from broader neuropathy and general health data. ScienceDirect+1

3. Alpha-lipoic acid (ALA)
ALA is an antioxidant used in some countries for diabetic neuropathy. Typical doses in studies are around 300–600 mg per day. The purpose is to reduce oxidative stress that may contribute to nerve damage. Mechanistically, ALA helps recycle other antioxidants (like vitamin C and glutathione) and may improve blood flow to nerves. Side effects can include stomach upset and, rarely, low blood sugar in people on diabetes medicine. Evidence in HMSN1 is not yet strong and use should be supervised. ScienceDirect+1

4. B-complex vitamins (especially B1 and B6, in safe doses)
Vitamins B1 (thiamine) and B6 (pyridoxine) are essential for energy metabolism and nerve function. Some CMT-related gene defects affect enzymes that use these vitamins. Supplement doses vary but must stay below high-toxicity levels, especially for B6. The purpose is to correct marginal deficiencies that may worsen neuropathy. Mechanistically, active forms of B1 and B6 act as coenzymes in many metabolic pathways, including those in neurons. Too much B6 can itself cause neuropathy, so dosing must be cautious. PMC+1

5. Vitamin B12 (oral or sublingual, when low-normal)
Even when not frankly deficient, some people with neuropathy may benefit from optimizing B12 levels. Oral doses often range from 500–1,000 µg daily. The purpose is to ensure enough B12 is available for myelin production and nerve repair processes. Mechanistically, B12 acts in methylation reactions and fatty acid synthesis that are vital for myelin. Evidence is stronger for other neuropathies than for HMSN1, so this is an adjunct only. PMC+1

6. Vitamin D (if insufficient)
When blood tests show low vitamin D, supplementation (often 800–2,000 IU daily, adjusted by doctors) supports bone and muscle health. The purpose is to reduce fracture risk and possibly improve muscle function in weak limbs. Mechanistically, vitamin D regulates calcium and phosphate metabolism and influences muscle fibers and immune function. It is an essential part of overall health rather than a specific HMSN1 treatment. ScienceDirect+1

7. Magnesium
Magnesium plays roles in nerve conduction and muscle relaxation. Oral doses vary (for example, 200–400 mg elemental magnesium per day), usually taken with food. The purpose is to correct deficiency and possibly reduce muscle cramps. Mechanistically, magnesium helps regulate ion channels and neuromuscular transmission. Too much magnesium can cause diarrhea or, in kidney disease, more serious issues, so medical advice is necessary. ScienceDirect

8. L-carnitine
L-carnitine helps transport fatty acids into mitochondria for energy production. Some neuropathies have been studied with carnitine supplements at doses such as 1–3 g per day. The purpose is to support muscle energy metabolism and reduce fatigue. Mechanistically, more carnitine may improve fatty acid oxidation in muscle and nerve cells, which could support endurance. Evidence for HMSN1 is limited but biologically plausible. ScienceDirect+1

9. Curcumin (turmeric extract)
Curcumin has anti-inflammatory and antioxidant properties. Typical supplement doses range from 500–1,500 mg per day of standardized extract, often with absorption enhancers. The purpose is to modestly lower chronic inflammation and oxidative stress that may affect nerves and joints. Mechanistically, curcumin modulates many signaling pathways, including NF-κB, and acts as a free-radical scavenger. It can interact with blood thinners, so medical review is needed. ScienceDirect

10. General antioxidant combinations (vitamin C, vitamin E)
Vitamin C and E are classic antioxidants. Some experiments in CMT models tested high-dose vitamin C, but large trials in CMT1A showed no meaningful clinical benefit at disease level. Modest dietary or supplement doses may still support overall health. The purpose is general support of tissue repair and immune function. Mechanistically, they neutralize free radicals and protect lipids and proteins from oxidative damage. Supplements should stay within guideline limits. Springer+2JAMA Network+2

---

Regenerative, stem cell and “immunity booster” drugs

At present, there are no approved regenerative or stem cell drugs that cure hereditary motor and sensory neuropathy type 1. The approaches below are either experimental or theoretical. They are included for educational purposes only; use outside clinical trials is not recommended.

1. Experimental gene-silencing therapies for PMP22 (CMT1A)
In CMT1A, extra copies of the PMP22 gene cause myelin problems. Researchers are testing antisense oligonucleotides and other gene-silencing tools to lower PMP22 expression. The purpose is to address the root genetic defect and allow better myelin formation. Mechanistically, these molecules bind to PMP22 mRNA and prevent it from being made into protein. Doses and schedules are only used within trials, with careful safety monitoring. Springer+2Taylor & Francis Online+2

2. Neurotrophic factors (e.g., NT-3 and related molecules)
Neurotrophins are natural proteins that support nerve survival and growth. Studies in animal models have tested neurotrophin-3 (NT-3) to improve nerve regeneration and muscle strength. The purpose is to enhance repair of damaged peripheral nerves. Mechanistically, neurotrophins bind to receptors on neurons and Schwann cells and activate growth and survival pathways. Any human use today is experimental and strictly controlled in research settings. MDPI+1

3. PXT3003 and similar combination therapies
PXT3003 is an investigational oral combination of baclofen, naltrexone and sorbitol studied specifically in CMT1A. Trials aim to see if it can slow progression and improve strength. The purpose is disease modification rather than just symptom control. Mechanistically, the components are believed to influence PMP22 expression and myelin stability. Doses are defined inside clinical protocols; the drug is not yet widely approved. Taylor & Francis Online+1

4. High-dose ascorbic acid (vitamin C) in CMT1A research
High-dose vitamin C (4 g/day) was one of the earliest candidate treatments for CMT1A. Large randomized controlled trials, however, did not show benefit compared with placebo. The purpose was to reduce PMP22 expression and support myelin repair, but mechanisms did not translate into clinical improvement. Today, high-dose vitamin C is not recommended as a disease-modifying treatment, though normal dietary intake remains important. JAMA Network+2The Lancet+2

5. Mesenchymal stem cell therapies (pre-clinical and early clinical)
Mesenchymal stem cells (MSCs) from bone marrow or fat have been explored in many neurological diseases. In peripheral neuropathy, they may secrete growth factors and anti-inflammatory signals. The purpose in research is to see whether MSCs can protect or repair nerves and myelin. Mechanistically, they act mainly via “paracrine” effects rather than turning into nerve cells themselves. Dosing and delivery (intravenous or local) are still being studied; this is not routine care. MDPI+2Taylor & Francis Online+2

6. Gene-corrected stem cell therapy (future direction)
Scientists are exploring the idea of taking a patient’s own stem cells, correcting the genetic defect in the lab, and then re-introducing the cells. The purpose would be to provide a lifelong supply of healthy Schwann cells or other support cells. Mechanistically, genome-editing tools like CRISPR are used to change harmful mutations in vitro, and corrected cells are expanded and transplanted. This approach is still in early research stages and is not clinically available for HMSN1. Frontiers+2Preprints+2

---

Surgical treatments

Surgery in hereditary motor and sensory neuropathy type 1 does not repair nerves but can correct deformities and improve function when conservative measures are no longer enough. Decisions must be made by an experienced orthopedic surgeon familiar with CMT.

1. Soft-tissue procedures and tendon transfers in the foot
In early or moderate deformity, surgeons may lengthen tight tendons, release the plantar fascia, and transfer stronger tendons to replace weak ones (for example, transferring a stronger tendon to lift the foot). The purpose is to balance muscle forces around the foot and ankle and reduce cavus deformity. Mechanistically, by changing where tendons attach, the surgeon re-distributes muscle pull to restore a more plantigrade (flat) foot and improve gait. PMC+2Medscape+2

2. Osteotomy (bone-cutting) procedures for cavus foot
When deformities are more rigid, bone cuts (osteotomies) of the heel bone or midfoot (such as the Dwyer or Akron dome osteotomy) can reposition bones into a more neutral alignment. The purpose is to create a stable, plantigrade foot that fits into shoes and braces more easily and reduces pain. Mechanistically, the surgeon removes or wedges small bone segments and fixes the new alignment with screws or plates so weight is distributed more normally. PMC+2Wiley Online Library+2

3. Arthrodesis (joint fusion) in severe deformity
In very advanced cases with painful, unstable joints, fusing certain joints in the foot (for example, triple arthrodesis) can provide permanent stability. The purpose is pain relief and improved standing and walking even when motion in those joints is sacrificed. Mechanistically, the surgeon removes damaged joint surfaces and fixes the bones together so they grow into one solid unit. PMC+2ResearchGate+2

4. Toe surgery for claw toes
Claw toes can cause pressure points, calluses and difficulty fitting shoes. Surgeries such as tendon releases, joint capsulotomies or small joint fusions straighten the toes. The purpose is to reduce pain, prevent ulcers on toe tips, and make footwear more comfortable. Mechanistically, soft-tissue balancing and sometimes bone shortening allow the toe to rest in a flatter position. ResearchGate+1

5. Spinal surgery for scoliosis (if significant)
Some people with HMSN1 develop scoliosis that progresses and affects posture or breathing. When bracing is not enough and the curve is large, spinal fusion surgery may be considered. The purpose is to stop curve progression, maintain sitting and standing balance, and protect lung function. Mechanistically, rods and screws are attached to the spine, the curve is gently corrected, and bone grafts are placed so the spine fuses in a straighter position. Orthobullets+2ScienceDirect+2

---

Preventions and lifestyle measures

Because HMSN1 is genetic, we cannot “prevent” the disease itself, but we can prevent many complications.

1. Avoid known neurotoxic drugs such as vincristine and some chemotherapy agents whenever possible; doctors should always check CMT-specific medication lists before prescribing. Charcot-Marie-Tooth Association+1

2. Protect the feet with well-fitting shoes, daily inspection, and quick treatment of blisters or cuts to prevent ulcers and infections. nhs.uk+1

3. Keep a healthy body weight to reduce strain on weak ankles and knees and lower fall risk. ScienceDirect

4. Exercise regularly but gently, following a therapist’s plan to maintain strength and balance without over-fatigue. ScienceDirect+1

5. Fall-proof the home, using grab rails, good lighting, non-slip mats and removing clutter. Medical Journals Sweden+1

6. Quit smoking and limit alcohol, as these can worsen circulation and nerve health. ScienceDirect+1

7. Control other medical conditions such as diabetes, thyroid problems or vitamin deficiencies that can add extra nerve damage. ScienceDirect+1

8. Stay up to date with vaccines to reduce severe infections that can weaken already fragile muscles. Mayo Clinic+1

9. Use orthoses and supports early, before severe deformities develop, rather than waiting until walking is extremely difficult. PM&R KnowledgeNow+2SAGE Journals+2

10. Seek genetic counseling for family planning and to understand risks for children and other relatives. PM&R KnowledgeNow+1

---

When to see doctors

You should keep regular follow-up with a neurologist, rehabilitation doctor (physiatrist), and, when needed, an orthopedic surgeon, even when you feel stable. Medical review is especially important when:

• New or rapidly worsening weakness, numbness or balance problems appear.

• Pain becomes severe, constant, or does not respond to usual medicines.

• You notice foot wounds, color changes, or swelling that do not heal.

• You have frequent falls, near-falls, or start avoiding walking because of fear.

• Breathing, sleep, or swallowing changes occur.

• Mood becomes persistently low, anxious, or you lose interest in usual activities.

In these situations, doctors can adjust therapy, check for additional problems (such as another type of neuropathy, vitamin deficiency, or spinal issue), and refer to services like surgery or psychological support. PM&R KnowledgeNow+2Mayo Clinic+2

---

What to eat and what to avoid

There is no special “HMSN1 diet”, but a healthy eating pattern can support nerve and muscle health and prevent extra problems like obesity or diabetes.

What to eat (5 key points)

1. Plenty of colorful vegetables and fruits for vitamins, minerals and antioxidants that support general tissue repair and immune function. ScienceDirect

2. Adequate lean protein from fish, eggs, beans, dairy or lean meats to support muscle maintenance and healing of any minor injuries. ScienceDirect

3. Healthy fats such as olive oil, nuts, seeds and fatty fish to provide omega-3 fatty acids that may support nerve membranes and reduce inflammation. ScienceDirect+1

4. Whole grains and high-fiber foods (oats, brown rice, lentils) to stabilize blood sugar and support long-term vascular health, which indirectly benefits nerves. ScienceDirect

5. Foods rich in B-vitamins and minerals, such as leafy greens, whole grains, dairy, meat and fortified cereals, to support nerve metabolism. PMC+2Preprints+2

What to avoid or limit (5 key points)

1. Excess alcohol, because it can directly damage peripheral nerves and worsen balance. ScienceDirect+1

2. Highly processed foods high in sugar and salt, which can lead to weight gain, high blood pressure and diabetes, adding extra stress on nerves and blood vessels. ScienceDirect

3. Very restrictive or crash diets, which may cause vitamin and mineral deficiencies that worsen fatigue and neuropathy. ScienceDirect+1

4. Large amounts of saturated and trans fats (fried foods, fast foods) that raise cardiovascular risk and may lessen overall mobility. ScienceDirect

5. Unregulated “mega-dose” supplements without medical review, especially high-dose vitamin B6, which can itself cause neuropathy. PMC+1

A registered dietitian familiar with neurological diseases can help tailor these guidelines to individual needs and cultural food preferences.

---

Frequently asked questions (FAQs)

1. Is hereditary motor and sensory neuropathy type 1 the same as Charcot-Marie-Tooth disease?
Yes. HMSN1 is an older name, and most doctors now use the term Charcot-Marie-Tooth disease type 1 (CMT1). Both describe inherited demyelinating neuropathies that mainly affect motor and sensory nerves in the limbs. Wikipedia+1

2. Is there a cure for HMSN1?
At the moment there is no cure and no approved drug that stops or reverses the nerve damage. Treatment focuses on rehabilitation, orthoses, pain control and prevention of complications. Research into gene therapies and disease-modifying drugs is active and promising, but still experimental. ScienceDirect+2Taylor & Francis Online+2

3. Will everyone with HMSN1 end up in a wheelchair?
Not necessarily. Many people stay able to walk with braces and therapy for decades. Some may need a wheelchair for long distances or later in life. The course varies depending on the exact gene change and individual factors like fitness, weight and support. Early, regular rehab helps preserve mobility. PM&R KnowledgeNow+2Orthobullets+2

4. Can exercise make the disease worse?
Well-planned, moderate exercise supervised by therapists is helpful, not harmful. Over-training to the point of extreme fatigue or repeated injury is not recommended. The key is a balanced program that includes strengthening, stretching and aerobic work at safe levels. ScienceDirect+1

5. What shoes are best for HMSN1?
Supportive shoes with firm heels, wide toe boxes, and enough depth for braces are usually best. Custom insoles and rockered soles are often needed to accommodate high arches and claw toes. An orthotist or podiatrist can help choose and adjust footwear. PMC+2SAGE Journals+2

6. Are children of a person with HMSN1 always affected?
In common autosomal dominant forms, each child has about a 50% chance of inheriting the gene change, but that does not mean they will be affected in exactly the same way. Genetic counseling helps families understand specific risks for their type. PM&R KnowledgeNow+1

7. Can diet alone treat HMSN1?
No. Diet cannot fix the genetic cause or fully repair damaged nerves. However, a balanced diet supports muscle and nerve health, helps maintain a healthy weight, and may reduce additional risk factors that could make symptoms worse. Diet is a partner to, not a replacement for, medical and rehab care. ScienceDirect+1

8. Are stem cell therapies available now for HMSN1?
Stem cell and gene-modified cell therapies are being studied in laboratories and early trials, but they are not standard treatments yet. Any clinic promising guaranteed stem cell “cures” outside approved trials should be approached with extreme caution. MDPI+2Frontiers+2

9. What medicines should people with HMSN1 be careful about?
Some drugs, especially certain chemotherapy agents like vincristine and some others, are known to be particularly toxic to peripheral nerves and are usually avoided or used with great caution. Before starting new medicines, people with CMT should ask their doctors and pharmacists to check CMT-specific medication lists. Charcot-Marie-Tooth Association+1

10. Does HMSN1 affect life expectancy?
For many people, HMSN1 mainly affects quality of life (mobility, pain, independence) but not lifespan. In more severe cases or when complications such as serious foot infections, severe scoliosis, or breathing problems occur, health can be more affected. Good preventive care helps lower these risks. PM&R KnowledgeNow+2Orthobullets+2

11. Can pregnancy worsen HMSN1?
Most people with HMSN1 can have pregnancies, but extra care is needed. Weight gain and changes in balance may temporarily increase falls and fatigue, and delivery planning should involve neurologists and obstetricians. So far, there is no clear evidence that pregnancy permanently accelerates disease, but every case is individual. ScienceDirect+1

12. How often should someone with HMSN1 see a neurologist?
Many experts suggest at least yearly checks, and more often if symptoms change or new treatments are being tried. This allows timely adjustments in braces, therapy programs, and medications, and early detection of complications. PM&R KnowledgeNow+2ScienceDirect+2

13. Are children with HMSN1 able to play sports?
Many can take part in low-impact sports such as swimming, cycling or adapted games, especially with braces and supervision. High-impact sports with high fall risk may need modifications. Therapists and doctors can help design safe physical activity plans that support social and physical development. Medical Journals Sweden+2Orthobullets+2

14. Where can families find reliable information and support?
National neuropathy or CMT organizations, academic hospital websites (like Mayo Clinic or NHS), and patient advocacy groups provide up-to-date, evidence-based information and support groups. These resources can also help connect families to expert centers and clinical trials. Charcot-Marie-Tooth Association+3Mayo Clinic+3nhs.uk+3

15. What is the most important thing to remember about HMSN1 treatment?
The most important message is that a team approach works best. Regular physical and occupational therapy, appropriate orthoses, careful pain management, healthy lifestyle choices, and emotional support together can greatly improve comfort and independence, even though we do not yet have a cure. Staying engaged with knowledgeable specialists keeps people ready for new therapies as they are discovered. Orthobullets+3PM&R KnowledgeNow+3ScienceDirect+3

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 31, 2025.